GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
These Phase 3 clinical studies are designed to evaluate the safety and efficacy of dotinurad compared to an active control ...
GlobalData on MSN
Arthrosi gains $153m for development of gout therapy
US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is ...
Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...
Gout is a type of inflammatory arthritis. It occurs when your blood has a buildup of uric acid. This acid causes crystals to form in a joint, which leads to ...
Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...
For researchers, including Georgetown University chemist Jennifer Swift, analyzing reptilian pee crystals presented an ...
Crystals "peed" by snakes could hold the key to treating kidney stones and gout in humans, say scientists. Researchers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback